(Q38173671)

30 August 2017

title

A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling (English)

1 reference

30 August 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Jihong Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yufeng Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Zheng Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yiyu Cheng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

1 November 2014

1 reference

30 August 2017

published in

Heart Failure Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

799-814

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366330%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10741-013-9417-4

12 June 2020

exact match

0 references

cites work

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Cellular basis of ventricular remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Ligand-directed signalling at beta-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The heart failure revascularisation trial (HEART): rationale, design and methodology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Cardiac oxidative stress in acute and chronic isoproterenol-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Involvement of ERK-RSK cascade in phenylephrine-induced phosphorylation of GATA4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Overexpression of Gs alpha protein in the hearts of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Critical role of transcription factor cyclic AMP response element modulator in beta1-adrenoceptor-mediated cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Myocyte adrenoceptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-adrenergic stimulation and myocardial function in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Type 1 phosphatase, a negative regulator of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

cAMP-binding protein Epac induces cardiomyocyte hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Small GTP-binding proteins and their regulators in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Epac proteins: multi-purpose cAMP targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Physical and functional interaction between calcineurin and the cardiac L-type Ca2+ channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Regulating gene transcription in response to cyclic AMP elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Phosphatases at the heart of FoxO metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

FoxO, autophagy, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Comparison of the lipolytic effects of norepinephrine and BRL 37344 in rat brown and white adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Upregulation of functional beta(3)-adrenergic receptor in the failing canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Functional beta3-adrenoceptor in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Nitric oxide: a unique endogenous signaling molecule in vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The biology of cyclic GMP-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

cGMP regulated protein kinases (cGK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

eNOS phosphorylation in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Effects of AT1- and beta-adrenergic receptor antagonists on TGF-beta1-induced fibrosis in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

STAT3 and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Transforming growth factor (TGF)-β signaling in cardiac remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

miRTarBase: a database curates experimentally validated microRNA-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Human Protein Reference Database--2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

microRNA: a master regulator of cellular processes for bioengineering systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Drugs for left ventricular remodeling in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

beta-Blocker therapy in heart failure: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Carvedilol in elderly patients with chronic heart failure, a 12 weeks randomized, placebo controlled open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9417-4

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure

21 January 2018

1 reference

12 December 2020

Long-term effects of bisoprolol compared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency

1 reference

12 December 2020

Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure

1 reference

12 December 2020

Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium

1 reference

12 December 2020

Calmodulin-dependent protein kinase II mediates signal transduction in apoptosis.

1 reference

12 December 2020

COMBODY: one-domain antibody multimer with improved avidity

1 reference

12 December 2020

Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases

1 reference

12 December 2020

Coupling function of endogenous alpha(1)- and beta-adrenergic receptors in mouse cardiomyocytes

1 reference

12 December 2020

Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling

1 reference

12 December 2020

The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly

1 reference

12 December 2020

Pressure overload hypertrophy and congestive heart failure. Where is the "Achilles' heel"?

1 reference

12 December 2020

Global cardiac remodeling after acute myocardial infarction: a study in the rat model

1 reference

12 December 2020

Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes

1 reference

12 December 2020

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

12 December 2020

Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system

1 reference

12 December 2020

Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling

1 reference

12 December 2020

Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome

1 reference

12 December 2020

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

1 reference

12 December 2020

Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

International Union of Pharmacology nomenclature of adrenoceptors

1 reference

12 December 2020

Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice

1 reference

12 December 2020

The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes

1 reference

12 December 2020

Activation of CaMKIIdeltaC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis

1 reference

12 December 2020

β-adrenoceptor regulates miRNA expression in rat heart

1 reference

12 December 2020

Molecular cloning and expression of glycogen synthase kinase-3/factor A

1 reference

12 December 2020

beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes

1 reference

12 December 2020

Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy

1 reference

12 December 2020

Experimental therapy of penehyclidine hydrochloride on paraquat-induced acute lung injury

1 reference

12 December 2020

Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Differential effects of isoproterenol on the activity of angiotensin-converting enzyme in the rat heart and aorta

1 reference

12 December 2020